{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:15:25Z","timestamp":1761167725809,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ghir.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T12:30:52Z","timestamp":1308486652000},"page":"238-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Remission of Cushing's disease with growth hormone replacement"],"prefix":"10.1016","volume":"21","author":[{"given":"Mustafa","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Atmaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2011.05.005_bb0005","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome:a opulation-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.005_bb0010","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2011.05.005_bb0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/BF03347498","article-title":"Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery","volume":"27","author":"Porpiglia","year":"2004","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ghir.2011.05.005_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3171\/jns.2000.93.5.0738","article-title":"Radiosurgery for Cushing's disease after failed transsphenoidal surgery","volume":"93","author":"Sheehan","year":"2000","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ghir.2011.05.005_bb0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","article-title":"The medical treatment of Cushing's syndrome","volume":"14","author":"Miller","year":"1993","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.ghir.2011.05.005_bb0030","first-page":"209","article-title":"Medical treatment of Cushing's disease: Overview and recent findings","volume":"29","author":"Praw","year":"2009","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.ghir.2011.05.005_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.2003.01922.x","article-title":"Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion","volume":"60","author":"Carroll","year":"2004","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2011.05.005_bb0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","article-title":"Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease","volume":"60","author":"Johannsson","year":"2004","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2011.05.005_bb0045","first-page":"167","article-title":"Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease","volume":"146","author":"Feldt-Rasmussen","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2011.05.005_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2265.1999.00738.x","article-title":"Growth hormone status following treatment for Cushing's syndrome","volume":"51","author":"Hughes","year":"1999","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2011.05.005_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022308429992","article-title":"Medical therapy of Cushing's disease","volume":"5","author":"Nieman","year":"2002","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2011.05.005_bb0060","first-page":"1","article-title":"Efficacy of Cabergoline in Uncured Cushing's disease (Persistent\/Recurrent) After Pituitary Surgery +\/\u2212 Radiotherapy","volume":"24","author":"Ranjan","year":"2010","journal-title":"Endocr. Pract."},{"year":"2007","series-title":"Cabergoline treatment in Cushing's disease: effect on hypertension, glucose metabolism and dyslipidemia. Presented at the 9th European Congress of Endocrinology, Budapest, Hungary","author":"Pivonello","key":"10.1016\/j.ghir.2011.05.005_bb0065"},{"issue":"1","key":"10.1016\/j.ghir.2011.05.005_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2011.05.005_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.005_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1510173","article-title":"Effects of chronic administration of PPARgamma ligand rosiglitazone in Cushing's disease","volume":"151","author":"Ambrosi","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2011.05.005_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/eje.1.02329","article-title":"Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease","volume":"156","author":"Pecori Giraldi","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2011.05.005_bb0090","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2005-1694","article-title":"Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue","volume":"91","author":"Paulsen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.005_bb0095","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1210\/jc.2002-021894","article-title":"Low-dose growth hormone inhibits 11_-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity","volume":"88","author":"Tomlinson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.005_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2265.1998.3641180.x","article-title":"The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11_-hydroxysteroid dehydrogenase activity","volume":"48","author":"Gelding","year":"1998","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2011.05.005_bb0105","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11_-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"39","key":"10.1016\/j.ghir.2011.05.005_bb0110","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1523\/JNEUROSCI.2190-07.2007","article-title":"Enhanced hippocampal long-term potentiation and spatial learning in aged 11beta-hydroxysteroid dehydrogenase type 1 knock-out mice","volume":"26;27","author":"Yau","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ghir.2011.05.005_bb0115","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2003-030286","article-title":"Local and systemic impact of transcriptional up-regulation of 11_-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity","volume":"88","author":"Wake","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.005_bb0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI113592","article-title":"Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle","volume":"82","author":"Stewart","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ghir.2011.05.005_bb0125","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1530\/eje.0.1430769","article-title":"Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults","volume":"143","author":"Tsch\u00f6p","year":"2000","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2011.05.005_bb0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","article-title":"Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous Cushing's disease or non-functioning pituitary adenoma","volume":"95","author":"Webb","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637411000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637411000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:47:18Z","timestamp":1761086838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637411000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1096637411000554"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2011.05.005","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remission of Cushing's disease with growth hormone replacement","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2011.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}